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It was demonstrated in the preceding paper (1) that incubation  of primary 
isolates of normal human amnion cells with specific rabbit antibody and normal 
human serum resulted in immune cellular injury as measured by two independ- 
ent criteria of cytotoxicity. It was further shown that  the factors in normal 
human serum which were required in addition to specific antibody for produc- 
tion  of  cytotoxicity were  indistinguishable  from  components  of  hemolytic 
complement and calcium and magnesium ions. Thus, no fundamental differences 
were  apparent  between  requirements  for  immune  injury  of  human  amnion 
cells  (immune cytotoxicity) and  immune injury of sheep or human  erythro- 
cytes (immune hemolysis) (2, 3). 
The sequence of action of the components of complement in immune hemoly- 
sis  was  deduced by Pillemer,  Seifter, and Ecker (4).  In further dissection of 
this complex system, Mayer, Levine, and  their associates showed that early 
events in immune hemolysis involved reactions between the sensitized erythro- 
cyte and the first and fourth components of complement (C'I and C~4) in the 
presence of  Ca  ++  .  The  resulting  complex could  then  react  with  the  second 
component of complement (C'2)  in the presence of Mg  ++, forming a  complex 
which could react with the third component (CI3)  in the absence of divalent 
cations. The latter reaction effected injury of the erythrocyte leading to hemoly- 
sis (2). The biochemical as opposed to the descriptive events in immune hemol- 
ysis were unknown. 
A  large body of evidence has  accumulated from this laboratory and  inde- 
pendently from Becker's laboratory that  C'I  is  a  proenzyme which may be 
activated by antigen-antibody reactions (5). The active enzyme is an esterase 
(C'I esterase) capable of hydrolyzing certain synthetic amino acid esters, such 
as  N-acetyl-L-tyrosine  ethyl  ester  and  p-toluenesulfonyl-L-arginine  methyl 
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ester, and of interacting with C'4 and possibly C'2. Human and various other 
serums contain a  naturally occurring inhibitor, a  heat-labile a2-globulin, which 
can  block,  under  appropriate  conditions,  both  the  esterolytic  and  comple- 
ment-interacting  properties  of  Cq  esterase  (6-9).  The  inhibitor,  partially 
purified from  human  serum  by ammonium  sulfate fractionation and  column 
chromatography,  contains only small amounts  of serum  trypsin and plasmin 
inhibitors (8). The relative specificity of such purified preparations of inhibitor 
provided an important reagent for studies on the functional role of C'I esterase 
in various immune phenomena requiring complement. 
Using partially purified preparations of human C~I esterase (10) and human 
serum inhibitor of C'I esterase (8) in appropriately separated reactions, it has 
been  possible to  demonstrate  that  a  reaction between  antigen-antibody and 
Cq esterase is the first detectable event in complement-fixation (9) and immune 
human  hemolysis  (Donath-Landsteiner  reaction  described  in  reference  3). 
The present paper is concerned with the initiating role of human  C'I esterase 
in immune  cytotoxicity with normal  human  amnion  cells and  specific rabbit 
antibody, using uptake of trypan blue as the index of cell death. The results 
of these  experiments represent a  partial biochemical definition of one  step of 
immune cellular injury. 
Materials and Methods 
Human  C'I Esterase.---C'l  was prepared from  pooled  human  serum  and  activated  to 
C'I esterase by published  procedures  (10). The preparation, at pH 7.4, ionic strength 0.15, 
was adsorbed at 1  °  with an equal volume of human erythrocytes (blood group AB, Rh-posi- 
five), centrifuged  free of all insoluble  material, diluted in barbital buffer of pH 7.4, ionic 
strength 0.15 to a concentration  of 10 units per ml., and stored in small aliquots at --20  °. 
Activity and solubility were unimpaired by storage for at least 1 month.  One unit of C'I 
esterase  is defined as that amount of enzyme which will liberate 0.5 micromol of fitratable 
acid during incubation for  15  minutes at  37 ° with N-acetyl-L-tyrosine ethyl ester under 
standardized conditions  of assay (6, 7). The preparation of Cq esterase  used contained 30 
#g. of nitrogen per unit of enzyme. 
Human Serum Inhibitor of Crl  g.sterase.--Inhibitor was  prepared by chromatography on 
a Dowex-2 chloride column of the supernatant from precipitation of human serum with 40 
per cent ammonium  sulfate (8). The final preparation, at pH 7.4, ionic strength 0.15, was 
stored in small aliquots at -20  ° at a concentration of about 30 units per ml. Activity and 
solubility were  unimpaired by storage for at least several months.  One  unit  of inhibitor 
stoichiometricaily  inhibits the esterolytic activity of 10 units of C'I esterase under standard- 
ized conditions of assay (7). The preparation of inhibitor used contained  8 #g. of nitrogen per 
unit. 
All other pertinent materials and methods are described in the preceding paper (1).  R1 
and R2, the human serum reagents deficient respectively in Cq and C% were prepared only 
by the method of dialysis. 
Design of Experiments.--Immune cytotoxicity was  separated into the following reaction 
stages. All centrifugations  were performed at 1000 r.p.m. (205 G). 
Reaxtion 1.--1.4  X  10  s human  amnion  cells  were  sensitized  with  rabbit  anti-human 
amnion q,~-globulin  at 22  °, centrifuged,  and washed with mixture 199 containing  10 per cent I. H.  LEP0W,  AND  A.  ROSS  1109 
complement-depleted human serum,  as  described in the preceding paper  (1).  The amount 
of ~2-globulin used corresponded to 60/~g. of nitrogen. 
Rec~tion//.--The  sensitized amnlon cells were reacted  for  30  minutes  at  15  °  with  0.5 
ml. of a  dilution of human Cq  esterase in mixture 199 containing 10 per cent complement- 
depleted human serum and then centrifuged and washed with 0.5 ml. of the same diluent at 
15  °  . The time and temperature of reaction were selected on the basis of parallel experiments 
on  the interaction of  pneumococcal  specific polysaccharide,  Type III-rabbit anti-Type III 
aggregates with human C'I  esterase.  These experiments showed  that interaction occurred 
within a  few minutes at low temperatures and was progressively inhibited at temperatures 
greater than 22  °  (9). The choice of 15  ° for this reaction with amnion cells was an arbitrary 
compromise between conditions favoring interaction and avoiding cold injury of the cells. 
Barbital buffer of pH 7.4, ionic strength 0.15,  with or without added Ca  ++ and Mg  ++, was 
used as diluent in experiments involving the use of salts of EDTA.  The sensitized amnion 
cells were reacted for 30 minutes at  15  ° with 0.5 ml. of a  solution in barbital buffer of C'1 
esterase and EDTA of indicated concentrations and then centrifuged and washed with 0.5 
ml. of barbital buffer at 15  °. This substitution of diluents was made because of previous find- 
ings that mixture 199 interfered with the chelation of Ca  ++ by EDTA (1). 
For experiments on the effect of premixing C'1 esterase with serum inhibitor of C'I esterase, 
the enzyme and inhibitor were incubated together in barbital buffer without added Ca++ and 
Mg++ for 10 minutes at 37  ° at concentrations 5-fold greater than desired. The mixtures were 
then diluted 1/5 in mixture 199  containing 10 per cent complement-depleted human serum, 
cooled to 15  °, reacted with sensitized amnion cells, and centrifuged and washed as described 
above. 
The washed  product  of  reaction II,  is designated,  for  convenience, as  an amnion cell- 
antibody-(C'l esterase) complex. 
Reaction llA.--This  reaction was performed  only in  experiments  designed  to  test  the 
effect of serum inhibitor of C'1 esterase on amnion cell-antibody-(C'l esterase) complexes; 
that is, on the product of reaction II. Such complexes were incubated under various condi- 
tions of time and temperature with 0.5 ml. of dilutions of inhibitor in mixture 199 containing 
10 per cent complement-depleted human serum and then centrifuged and washed at room 
temperature with 0.5 ml. of the same diluent. 
Rec~tion Ill.--Products of reactions Il or IIA were incubated for 30 minutes at 37  ° with 
0.5 ml. of indicated amounts of various human serum reagents diluted in mixture 199. Barbital 
buffer with added Ca  ++ and Mg++ was substituted for mixture 199 in experiments involving 
the use of salts of EDTA.  Although reaction IlI was treated operationally as a  single step, 
it was recognized that it was a composite of several reactions requiring, as will be shown below, 
the participation of C'2, C'3, C'4, and Mg  ++. 
Uptake of Trypan Blue.--At the completion of reaction HI, 0.25 ml. of 1 per cent trypan 
blue was added at once to the total reaction mixture.  The tube was gently agitated for 2 
minutes and the per cent of stained cells estimated as described in the preceding paper (1). 
Comrols.--Appropriate  diluents were  substituted  for  the various  reagents  used  at  each 
reaction stage.  These controls were otherwise manipulated  in exactly the same manner as 
experimental mixtures. 
EXPER~r~.NTAL 
I.  Effect  of Comentration  of C~1 Esterase  on Immune  Cytotoxicity.--Amnion 
cells  sensitized  with  antibody  were  reacted  with  various  dilutions  of  human 
Ctl  esterase,  centrifuged,  and washed,  as described above. The resulting com- 
plexes  were  then  incubated  with  3  units  of  R1  as  a  source  of  Cr2,  CP3,  and 1110  IMMUNE  CELLULAR  INJURY.  II 
CP4. Cytotoxicity, as measured by uptake  of trypan blue,  was observed only 
when  cells were exposed to antibody,  C~I  esterase, and  R1  (Table I).  If any 
one of these constituents was omitted, detectable cellular injury did not occur. 
The minimal concentration of C'I esterase effecting optimal cytotoxicity under 
the  conditions of  this  experiment  was  0.02  unit,  corresponding  to  about  0.6 
gg. of nitrogen in the preparation employed. It is emphasized that C'I esterase 
did not  contain hemolytic C'I  activity but  was  nevertheless capable of pre- 
paring sensitized amnion cells for injury by R1. 
TABLE I 
Effect of Concentration of C'1 Esterase on Immune Cytotoxicity 
Reaction I  (22  °, 10 min.)  Reaction II  Reaction III  (15  °, 30 rain.)  (37  °, 30 rain.)  Cytotoxieity 
Amnion cells  Antibody*  C'I esterase  R1  Stained cells 
No./025 ml. 
1.4  )<  10  5 
1.4  )<  lO  s 
1.4  )<  10  ~ 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  10  6 
1.4  X  10  5 
1.4  >(  10  5 
1.4  X  10  5 
1.4  X  10  5 
d~n/0.25  mL 
1/20 
1/20 
1/20 
1/20 
1/2o 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
0 
unit/0.5 ml. 
1.0 
0.25 
0.06 
0.04 
0.02 
0.01 
0.005 
0.0025 
0.0013 
0 
C 
1.0 
1.0 
unit~0.5  ml. 
3 
3 
3 
3 
3 
3 
3 
3 
3 
#er cent 
89 
91 
90 
96 
90 
65 
58 
29 
19 
6 
12 
11 
12 
* CF titei, 1/384; see previous paper (1). 
II.  Requirement for  C'2,  C3,  and  C'4 for  Immune  Cytotoxicity  Following 
Interaction of Cell-Antibody Complex with C'1 Esterase.  Amnion cells sensitized 
with antibody were reacted with 0.05 unit of C'I esterase in the usual manner 
and then incubated with 3 units of R1, R2, R3, or R4. Significant cytotoxicity, 
compared with  controls,  occurred only when  reaction III  was  performed  in 
the presence of C'2,  C'3, and C'4 (R1)  (Table II). It had been demonstrated 
previously that C'I, CP2, C'3, and C'4 were required for immune cytotoxicity 
(1). This experiment therefore indicated that C'I esterase could be substituted 
for Ctl and that R1 was a satisfactory source of C'2, Ct3, and Ct4. 
IIL  Effect  of  Various  Concentrations  of CPl  Esterase,  Heat-Inactivated  C1 
Esterase,  and R1 on Immune Cytotoxicity.--Amnion  cells sensitized with anti- 
body were reacted with 0.05 or 0.5 unit of C~I esterase or heat-inactivated C~I I.  H.  LEPOW~ AND  A.  ROSS  1111 
esterase (56  °, 30 minutes) in the usual manner and then incubated with various 
concentrations of R1.  The results  (Table III) demonstrated that heat-inacti- 
vated esterase,  which is without esterolytic and complement-interacting prop- 
erties, was inactive in preparing sensitized amnion cells for immune injury. The 
data also showed that the concentration of R1 rather than of C~I esterase was 
the limiting  factor in  producing cytotoxicity under  conditions of the  experi- 
ment. The extent of uptake of trypan blue increased with increasing concentra- 
tion of R1 but was not affected by increasing the concentration of C'I esterase 
in reaction II. Optimal cytotoxicity was achieved with either 0.05 or 0.5 unit of 
TABLE II 
Requirement for C'2, C'3, and C'4 for Immune Cytotox'idty  Following  Interaction of 
Cell-Antibody Complex with C'I Esterase 
Reaction I  (22  °, 10 rain.)  Reaction II (15  °,  Reaction III (37  °,  30 rain.)  30 min.)  Cytotoxicity 
Anmion cells  Antibody  C'I esterase  Complement reagent  Stained cells 
No./0.25 ml. 
1.4  X  105 
1.4  X  105 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  10  ~ 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  IO  5 
d~ut~n/O.2Y ml. 
1/20 
1/20 
1/20 
1/20 
unit~0.5 ml. 
0.05 
0.05 
0.05 
0.05 
un@UO.Y ml. 
3 units R1 
3 units R2 
3 units R3 
3 units R4 
1/20  o 
1/20  0 
1/20  o 
1/2o  o 
1/20  o 
1/2o 
3 units R1 
3 units R2 
3 units R3 
3 units R4 
0 
0.05  0 
p~t ~t 
97 
13 
6 
5 
18 
15 
7 
5 
esterase in reaction II and 3 units of R1 in reaction III. This amount of R1 fre- 
quently caused a  small amount of cytotoxicity in  controls unexposed to  C'I 
esterase, as shown in Table III. 
IV. Sequence of Reactants  Required for Immune Cytotoxicity.--These experi- 
ments were designed to test the effect of varying the order in which antibody, 
C'I  esterase  and  R1  were  reacted  with  human  amnion  cells.  Individual re- 
actants were added to cells in individual reaction stages in sequences indicated 
in Table IV. Following each reaction,  the cells  were centrifuged and the sedi- 
ments washed with 0.5 ml. of mixture 199 containing 10 per cent complement- 
depleted human serum. Reactions involving antibody (0.25 ml. of 1/20 dilution 
of rabbit anti-human amnion -),~-globulin) were performed at 22  ° for 10 minutes; 
R1  (3 units),  37 ° for 30 minutes;  C'I esterase  (0.1  unit),  15  ° for 30 minutes, 1112  IMMUNE  CELLULAR  INJURY.  II 
TABLE  HI 
Effect of Various Concentrations of C'I Esterase, Heat-Inactivated C'I Esterase, and 
R1 on Immune Cytotoxiclty 
Reaction I  (22  °, i0 rain.) 
Amnion cells 
No./025 ral. 
1.4  X  10  5 
1.4  X  10  5 
1.4  X  105 
1.4  X  106 
1.4  X  106 
1.4  X  l0  s 
1.4  X  105 
1.4  X  105 
Antibody 
dilutlon/O.M ral, 
i  1/20 
! 
!  1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
Reaction II (15  °, 30 rain.) 
C'I esterase 
unlt/0.5  ral. 
0.05 
0.05 
0.05 
0.05 
0.5 
0.5 
0.5 
0.5 
Reaction III 
(37  °, 30 min.) 
Rl 
units/O.5  ml. 
1 
2 
3 
4 
1.4  X 
1.4  X 
10  ~ 
lO  5 
1.4  X  l0  s 
1.4  ×  10  5 
1.4  X  I0  s 
1.4  X  10  5 
1.4  X  105 
1.4  X  105 
1/20 
1/20 
1/20 
1/20 
1/20 
1/2o 
1/20 
1/20 
0.05--heated* 
0.5--heated 
0 
0.05 
0.5 
0 
0 
0 
Cytotoxicity 
Stained Cells 
per cen~ 
31 
75 
89 
95 
26 
79 
92 
96 
18 
16 
7 
10 
6 
11 
19 
25 
* Cq esterase previously heated for 30 minutes at 56  °. 
TABLE  IV 
Sequence of Reactions Required for Immune Cytotoxldty 
Order of reactants* 
Cell +  antibody -{- C'I esterase +  R1 ...................... 
Cell +  diluent -{- C'I esterase -{- R1 ....................... 
Cell -{- antibody +  C'I esterase +  diluent ................... 
Cell +  antibody -t- diluent -[- R1 ........................... 
Cell +  C'I esterase -{- antibody -t- R1 ...................... 
Cell +  antibody +  R1  -{-  C'I  esterase ...................... 
Cytotoxicity 
Stained cells 
per cen~ 
87 
12 
9 
10 
6 
14 
* For explanation, see text. 
except when C'I esterase was used as the final reactant and the reaction was per- 
formed at 37  ° for 30 minutes. 
Immune cytotoxicity was observed only when the  amnion cells  were  first 
reacted with antibody, then with C~I esterase, and finally with R1 (Table IV). I. H. LEPOW, AND A.  ROSS  1113 
Omission of any one of these reactants or variation of the sequence of reactants 
resulted in absence of cytotoxicity. It was concluded that  Cq  esterase could 
react with amnion cells only after the cell had reacted with antibody and that 
only the product of the reaction between sensitized amnion cells and C'I esterase 
was susceptible to injury by C'2, C'3, and C'4. 
V. Requirement for Ca++  for Formation of Amnion Cell-Antibody-(Cq Esterase) 
Complex.--Amnion  cells  sensitized  with antibody were reacted  in  the  usual 
manner with 0.05 unit of Cq esterase in the presence and absence of 5 X  10-  3 
sodium, magnesium, or calcium salts of EDTA. The salts of EDTA, at pH 7.4 
TABLE V 
Requirement for Ca  ++ for Formation of A mnion Cdl-Antibody-(Cq Esterase 
Reaction I  (22 °, 10 min.) 
Amnion cells  [ 
No./O.Z5 ml. 
1.4  X  105 
1.4  X  10  ~ 
1.4  X  105 
1.4  X  105 
1.4  X  105 
1.4  X  105 
1.4  X  l0  s 
1,4  X  105 
1.4  X  105 
1.4  X  105 
Reaction II (15  °, 30 mill.)*  Reaction HI 
Complex 
Antibody 
d#ution/ 
0.25mi. 
C'I esterase -b EDTA 
u.i~O.$m|.  5XIO-iM 
(37  °, 30 rain.) 
R1 
~ni~/O.Sml. 
Cytotoxicity 
Stained cells 
per ¢~t 
1/20 
1/20 
1/20 
1/2o 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
0.05 
0.05 
0.05 
0.05 
0 
0 
0.05 
0 
0 
0 
Naa EDTA 
Na~Mg EDTA 
Na2Ca EDTA 
Na3 EDTA 
Na~Mg EDTA 
Na~Ca EDTA 
3  75 
3  16 
3  19 
3  88 
0  16 
3  9 
0  4 
3  11 
3  9 
3  3 
* Barbital buffer without added Ca++ and Mg++ used as diluent and for washing of com- 
plexes; see text. 
and ionic strength 0.15, and the C'I esterase were diluted in barbital buffer. The 
product of the reaction was washed with 0.5 ml. of barbital buffer and then in- 
cubated with 3 units of R1 diluted in mixture 199. Cytotoxicity was inhibited 
by both the sodium and magnesium salts of EDTA but not by the calcium salt 
of EDTA (Table V). None of the salts of EDTA was cytotoxic in the absence 
of C'I esterase. These results were consistent with a requirement for Ca  ++ for 
the formation of amnion cell-antibody-(C'l esterase) complex. 
VI. Requirement for Mg  ++ for Cytotoxic Activity of R1 on Amnion Cell-Anti- 
body-(C'l Esterase) Complex.--Sensitized amnion cells were reacted in the usual 
manner with 0.1 unit of C'I esterase diluted in mixture 199 containing 10 per 
cent  complement-depleted  human  serum.  The  washed  complexes  were  then 
incubated with 3 units of R1 in the presence and absence of 5 X  10  -3 ~  sodium, 
magnesium, or calcium salts of EDTA, using barbital buffer as diluent.  Cyto- 1114  IM2~UNE CELLULAR INJURY. II 
toxicity was inhibited only by the sodium salt of EDTA (Table VI). These re- 
sults were consistent with a  requirement for Mg  ++ for the cytotoxic activity of 
R1  on  amnion cell-antibody-(C'l esterase)  complexes. The reaction with  R1, 
operationally treated as a single reaction, was a resultant of a series of reactions 
involving  several components  of  complement.  No  attempt  was  made  to  de- 
termine the precise locus of action of Mg  ++ in this reaction sequence. 
VII.  Inhibition  of Immune  Cytotoxicity  by  Human  Serum  Inhibitor  of C'I 
Esterase.--A. Effect of Premixing C'1  Esterase and Inhibitor.---At  this point in 
the  investigation, it  had  been  shown  that  a  partially purified preparation of 
TABLE VI 
Requirement for Mg  ++ for Cytotoxic Activity of R1 on Amnion Cell- 
Antibody- (C 1 Esterase) Complex 
Reaction II  Reaction I (22  °, 10 rain.)  (15  °, 30 rain.)  Reaction  III (37  °, 30 rain.)*  Cytotoxicity 
Amnion cells  Antibody  C'I esterase  R1 + EDTA  Stained  cells 
No./0.25 tal. 
2.4  X  SO  s 
1.4  X  105 
2.4  X  10  s 
1.4  X  10  ~ 
1.4  X  SO  s 
1.4  X  SO  s 
2.4  X  l0  s 
1.4  X  SO  s 
1.4  X  l0  s 
1.4  X  l0  s 
dilut~n/ 
0.25 ml. 
1/20 
1/20 
2/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
unit/0.5  ml.  units/0.5  ml. 
0.I  3 
0.1  3 
0.1  3 
0.1  3 
0  0 
0  3 
0.1  0 
0.1  0 
0.1  0 
0.1  0 
5 X 101M 
Na3 EDTA 
Na2Mg EDTA 
Na2Ca EDTA 
Naa EDTA 
Na2Mg EDTA 
Na2Ca EDTA 
96 
5 
90 
94 
9 
12 
8 
7 
8 
5 
* Barbital buffer with added Ca  ++ and Mg++ used as diluent; see text. 
human  C'1  esterase could participate in a  reaction leading to  immune  cyto- 
toxicity. The  identity of  an  active  constituent  in  this  preparation  with  C'I 
esterase rested on two major observations: (a) the preparation could be substi- 
tuted for C'I and prepared the sensitized amnion cell for injury by C'2,  C'3, 
and C'4; and (b) the activity of the preparation in immune cytotoxicity, as well 
as in esterolysis and ability to interact with complement, was destroyed during 
heating for  30  minutes at  56  ° .  Additional evidence for  the functional role of 
Cq esterase in immune cytotoxicity was obtained in experiments which utilized 
partially purified human serum inhibitor of C'I esterase as an agent for blocking 
the effect of C'I esterase. 
Enzyme  and inhibitor or heat-inactivated inhibitor (60  ° ,  30 minutes)  were 
diluted in barbital buffer, mixed at concentrations 5-fold greater than desired, I.  H.  LEPOW, AND  A.  ROSS  1115 
and incubated for 10 minutes at 37 °. The mixtures were then diluted ~  in mix- 
ture 199 containing 10 per cent complement-depleted human  serum, cooled to 
15 °, reacted with sensitized amnion ceils in the usual manner,  and then incu- 
bated with 3 units of R1. Partially purified inhibitor in sufficient concentration 
completely inhibited the ability of 0.05 unit of C'1 esterase to prepare sensitized 
amnion cells for immune cytotoxicity (Table VII). If stoichiometric interaction 
of enzyme and inhibitor were valid at the low concentrations employed in this 
TABLE VII 
Inhibit~on of Immune Cytotoxicity by Human Serum Inhibitor of C'1 Eslerase: Effect 
of Premixing C'I Esterase and Inhibitor 
Reaction I (22  °, 10 min.) 
Amnion cells 
No./0.25 ml. 
1.4  X  105 
1.4  X  105 
1.4  X  105 
1.4  X  105 
1.4  X  10  s 
1.4  X  105 
1.4  X  105 
1.4  X  I05 
1.4  X  10  ~ 
1.4  X  10  ~ 
1.4  X  105 
1.4  X  105 
Antibody 
d~utioa/Od5 ml 
1120 
1/2o 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
1/20 
Reaction  III 
Reaction II (15  °, 30 min.)  (37  °, 30  Cytotoxieity 
rain.) 
C'I Esterase(E)  + Inhibitor (EI) 
unit/0.5 ml.  uniUO.SmL 
0.05 E 
0.05E  +  0.0025  EI 
0.05E  +  0.0075  EI 
0.05E  +  0.01EI 
0.05E  +  0.02EI 
0.05E  -4-  0.04EI 
0.05E  -4-  0.08 EI 
0.05 E  +  0.04 EI-heated* 
0.05 E  +  0.08 EI-heated 
0.05 E 
R1  Stained  cells 
!units/0.5 ml.  per cent 
3  93 
3  71 
3  44 
3  24 
3  22 
3  9 
3  10 
3  86 
3  82 
0  7 
3  9 
0  6 
* Inhibitor previously heated for 30 minutes at 60  °. 
experiment, the amount of inhibitor for complete inhibition should have been 
0.005 unit (0.04 #g. of nitrogen). However, at this level of inhibitor, only partial 
inhibition was observed. Complete inhibition was achieved at a  concentration 
of inhibitor of 0.04 unit, corresponding to 0.32 ttg. of nitrogen in the preparation 
of partially purified inhibitor employed. Heat-inactivated inhibitor at concen- 
trations of 0.04 and 0.08  unit was inactive or only slightly active in blocking 
the functional activity of C'I esterase. 
B.  Effect of Incubating Amnion Cell-Antibody-(C1  Esterase)  Complexes with 
Inhibitor.---The  preceding  experiment  demonstrated  that  it  was  possible  to 
block the functional activity of C'I esterase in immune cytotoxicity by incuba- 
tion of the enzyme with serum inhibitor of C'I esterase prior to interaction with 1116  CELLULAR  INJURY. II 
sensitized  amnion  cells.  Incubation  of  preformed  amnion  cell-antibody-(C'l 
esterase) complexes with inhibitor could also diminish or prevent the subsequent 
cytotoxic activity of R1. 
Sensitized amnion cells were reacted with 0.1 unit of C'I esterase in the usual 
manner and then incubated for 60 minutes at 22 ° with various dilutions of par- 
tially purified human serum inhibitor of C'I esterase. Mter centrifugation and 
washing, the complexes were further reacted with 3  units of R1. The suscepti- 
bility to cytotoxicity of the amnion cell-antibody-(C'l esterase) complexes de- 
TABLE VIII 
Inhibition of Immune Cytotoxicity by Human Serum Inhibitor of C'I Esterase:  Effect 
of Incubating Amnlon Cell-Antibody-(C'l Esterase)  Complexes  with Inhibitor 
Reaction I (22", 10 rain.)  Reaction II  Reaction  IIA  Reaction  III  (15  °, 30 mln.)  (22  °, 60 rain.)  (37  °, 30 rain.)  Cytotoxicity 
Amnion cells  Antibody  C'I esterase  Inhibitor  R1  Stained cells 
No./0.25 ml. 
1.4  X  105 
1.4  X  105 
1.4  X  l0  s 
1.4  X  105 
1.4  X  l0  s 
1.4  )<  105 
1.4  X  105 
1.4  X  l0  s 
1.4  X  105 
1.4  X  105 
1.4  X  105 
1.4  X  105 
d~ulion/ 
o.g5 mL 
1/20 
1/20 
1/2o 
1/2o 
1/20 
1/20 
1/20 
1/20 
i/2o 
1120 
1/20 
1/20 
unit/0.5 ml. 
0.1 
0.I 
0.1 
0.1 
0.1 
0.1 
0.1 
0 
0 
0.1 
0 
0 
unit/0.5 mr. 
0 
0.06 
0.12 
0.25 
0.5 
1.0 
1.0--heated* 
0 
0 
0 
1.0 
1.0 
units/0.5 mL 
3 
3 
3 
3 
3 
3 
3 
0 
3 
0 
0 
3 
p~r C'~t 
83 
66 
59 
47 
33 
23 
77 
* Inhibitor previously heated for 30minutes at60  °. 
creased  during  incubation  with  increasing  concentration  of  inhibitor  (Table 
VIII). More than  70 per cent inhibition was effected by 1.0 unit of inhibitor 
under  the  conditions of this experiment. The  same  concentration  of heat-in- 
activated inhibitor had only slight or absent inhibitory activity. 
DISCUSSION 
It had been shown previously that specific antibody and the components of 
hemolytic complement  were  required  for  immune  cytotoxicity with  primary 
isolates of normal human  amnion cells (I). These observations have been ex- 
tended to an initial separation of reaction stages which are summarized in the 
following schematic sequence: I.  H.  LEPOW,  AND  A.  ROSS  1117 
I.  Human amnion cell +  rabbit "y~-globulin  antibody -* Amnion cell-antibody 
II.  Amnion cell-antibody +  human  C'l  esterase  Ca**~ Amnion cell-antibody-(Cq 
esterase) 
Ill. Amnion cell-antibody-(C'l esterase) +  Ct2 +  C~3 +  C'4  Mg~> Cell death 
Attention has been directed primarily to reaction II and the initiation of com- 
plement action in immune cytotoxicity by Ctl esterase. Evidence for this func- 
tional role of CI1 esterase has been obtained from several observations: 
1.  The requirement for C11 in immune cytotoxicity (1) was fulfilled by par- 
tially purified preparations of human Cq esterase which were devoid of hemo- 
lytic C~1 activity by the usual methods of assay (5). The amount of enzyme re- 
quired was less than 1 ~g. of nitrogen in an impure fraction. 
2.  Inactivation of the enzyme by heating for 30 minutes at 56  ° abolished the 
activity in reaction II. 
3.  Incubation of Cq esterase with a partially purified preparation of human 
serum inhibitor of C~1 esterase prevented the formation of an active amnion 
cell-antibody-(Ctl  esterase)  complex.  The amount of inhibitor required  was 
greater than the predicted stoichiometric quantity for the enzyme concentra- 
tion employed. However, partial inhibition of CI1 esterase was observed with 
0.04 ~g. and complete inhibition with 0.32 #g. of inhibitor nitrogen in the pres- 
ence of excess enzyme. 
4.  Incubation of an active amnion ceU-antibody-(C'l esterase) complex with 
partially purified inhibitor greatly diminished the extent of reaction III. Rela- 
tively high concentrations of inhibitor were required for this purpose. 
5.  Inactivation of the inhibitor by heating for 30 minutes at 60  ° also abol- 
ished nearly completely its inhibitory activity in preventing the formation of 
an active amuion cell-antibody-(C'l esterase)  complex or in blocking the ac- 
tivity of a pre-formed active complex. 
6.  The formation of an active amnion cell-antibody-(Cq esterase) complex 
required the presence of Ca  -~, an ion known to be required for immune cyto- 
toxicity (1)  and for the interaction of other antigen-antibody complexes with 
C'1 (2, 3, 5). 
A key line of evidence for the functional activity of Cq esterase was derived 
from experiments on inhibition of immlme cytotoxicity by partially purified 
preparations of a human serum inhibitor of Cq esterase. The inhibitor, a natu- 
rally occurring heat-labile, a~-globulin, stoichiometrically  inhibits the esterolytic 
activity of relatively high concentrations of C'I esterase (7, 8). Because of limi- 
tations of sensitivity of the esterolytic assay for CPl esterase, no information is 
available as yet on the stoichiometry of interaction of enzyme and inhibitor at 
very low concentration. The failure to achieve complete inhibition of immune 
cytotoxicity with concentrations of inhibitor which were calculated to be stoi- 
chiometricaUy equivalent to the small amount of enzyme employed in the ex- 
periments reported here (Table vii) cannot therefore be interpreted rigorously 1118  IMMUNE CELLULAR INJURY. II 
at this time. However, partial inhibition could be achieved under these condi 
tions with only 40 millimicrograms of inhibitor nitrogen in a fraction with only 
small amounts of trypsin and  plasmin inhibitors.  This suggested strongly that 
inhibition of immune cytotoxicity was indeed a result of inhibition of C'I ester- 
ase. Assuming a molecular weight of 100,000 and a nitrogen to protein factor of 
6.25,  partial inhibition was observed at a protein concentration of 5 )<  10  -9 M 
in a non-homogeneous preparation. 
It is emphasized that this profound effect of the serum inhibitor could only be 
demonstrated by appropriate separation of reactions. When complement action 
was permitted to occur in a single reaction stage, as in the previous study (1), 
immune cytotoxicity proceeded in the presence of normal human serum which 
contains an average of 6.4 units of inhibitor per ml. (7). An explanation for this 
apparent paradox is emerging from kinetic studies of the relative rates of reac- 
tion of low concentrations of C~I esterase with inhibitor and with C'4 (9). These 
studies, still in progress, suggest that further action of complement (interaction 
of CPl esterase with C'4) proceeds at a much faster rate than inhibition of C'I 
esterase by serum inhibitor at enzyme concentrations used in the present in- 
vestigation. They also indicate that  the rate of interaction of enzyme and in- 
hibitor decreases with  decreasing concentration of either reactant.  Since the 
actual concentration of CPl esterase present on amnion cell-antibody-(C'l ester- 
ase)  complexes is not known but  is  probably less  than  the  concentration of 
enzyme used for reaction, these data perhaps account for the relatively high 
concentration of inhibitor required to block the activity of amnion cell-anti- 
body-(Cq esterase) complexes (Table VIII). 
No attempt has been made to determine the sequence of action of the com- 
ponents C~2, C~3 and C'4 in reaction III. It was demonstrated, however, that 
all of these components and Mg  ++ were required for completion of reaction III 
and that the sequence of reactions I, II and III could not be varied without loss 
of cytotoxicity. It would be inferred from previous studies of immune hemoly- 
sis that Ct4, C'2, and C~3 acted in that order and that Mg  ++ was involved in the 
action of C'2 (2). 
It is noteworthy that in several systems which have been studied, an early 
event in the action of complement has been found to be the formation of anti- 
gen-antibody-(C'l  esterase)  complexes.  Initiation  of complement  activity in 
immune  cytotoxicity, immune  human  hemolysis  (3),  immune  hemolysis  by 
guinea pig complement of sheep erythrocytes sensitized with rabbit antibody 
(11-14), and complement-fixation (9) appears to be dependent on activation of 
a proenzyme (Ctl) and subsequent action of the active enzyme (C~I esterase). 
Diverse functions of complement would seem therefore to follow mechanisms of 
action which at least initially are identical and for which a partial biochemical 
explanation is  available. I.  H.  LEPOW, AND A.  ROSS  1119 
SUMM&RY 
An initial  separation of reaction  stages in  immune cytoxicity is described. 
Primary isolates of normal human amnion cells were reacted first with specific 
rabbit "/~-globulin  antibody, then with human C'I esterase in the presence of 
Ca  q+, and finally with human C'2, C'3, and Ct4 in the presence of Mg  ++. Cyto- 
toxicity, as measured by uptake of trypan blue, occurred only when these re- 
actions were performed in the order given and did not occur when any of the 
constituents was omitted. Inhibition of immune cytotoxicity was achieved with 
partially purified preparations of human serum inhibitor of C'I esterase under 
certain experimental conditions. 
The data are discussed in relation to the role of Cq esterase in initiating com- 
plement action and the partial biochemical definition of an early event in im- 
mune cytotoxicity. 
Mrs. Antoinette L. Brown and Mr. Wha-Suk Lee provided technical assistance. Dr. Jack 
Pensky and Mr. Goldwin Hughes prepared the partially  purified fraction of human  serum 
inhibitor of C'I esterase. 
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